dihydroergocryptine
This page covers all dihydroergocryptine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 7.
Targets
5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 7
Marketed (1)
- Dihydroergocriptine · Hematology
Patent intelligence
- dihydroergocryptine patent landscape — aggregated cliff calendar, attackable patents, originator estates